Earnings Call · Q1 FY2024·2024-05-08

Q1 24EPS -13.68%·Rev n/aQ4 23EPS -42.27%·Rev n/aQ3 23EPS -77.63%·Rev n/aQ2 23EPS -8.06%·Rev n/a⚠ consensus missing

CYTOKINETICS INC CYTK

Diane Weiser — Senior Vice President of Corporate Affairs

Robert I. Blum — President and Chief Executive Officer

Fady Malik — Executive Vice President of Research and Development

Stuart Kupfer — Executive or Senior Leader in Clinical Development (likely EVP or SVP) - inferred from context

Andrew Callos — Senior Vice President, Commercial or similar (in charge of market development and commercial strategy)

Robert Wong — Chief Financial Officer

−1.9%1d on move date−2.5% vs SPY3d−11.3%5d−7.3%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CYTK calls or request research access.

More CYTK calls Browse calls Request research access